BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14765514)

  • 1. Global access to treatment: achievements and challenges.
    Cameron E; Gupta A
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):59-71. PubMed ID: 14765514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging HIV-related human rights achievements through a Framework Convention on Global Health.
    Buse K; Eba P; Sigurdson J; Thomson K; Timberlake S
    Health Hum Rights; 2013 Jun; 15(1):E96-110. PubMed ID: 25006095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV vaccines: current challenges and future directions.
    Avrett S; Collins C
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):1, 20-5. PubMed ID: 14765474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil.
    Rosenberg ST
    Dev World Bioeth; 2014 Aug; 14(2):83-91. PubMed ID: 24750542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-related stigma and discrimination--the epidemic continues.
    de Bruyn T
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):8-14. PubMed ID: 14765477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to affordable HIV/AIDS drugs: the human rights obligations of multinational pharmaceutical corporations.
    Ferreira L
    Fordham Law Rev; 2002 Dec; 71(3):1133-79. PubMed ID: 12523370
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of activists in access to HIV and tuberculosis treatment and prevention.
    Geffen N
    Curr Opin HIV AIDS; 2017 Jul; 12(4):398-402. PubMed ID: 28463853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Framework Convention on Global Health: A tool for empowering the HIV/AIDS movements in Senegal and South Africa.
    Scheepers E
    Health Hum Rights; 2013 Jun; 15(1):E87-95. PubMed ID: 25006094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug policy in Canada--the way forward.
    Kerr T; O'Briain W
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):1, 27-32. PubMed ID: 14765475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
    Halliburton M
    Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of intellectual property rights in treatment access: challenges and solutions.
    't Hoen E; Passarelli CA
    Curr Opin HIV AIDS; 2013 Jan; 8(1):70-4. PubMed ID: 23201855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barcelona 2002: law, ethics, and human rights. Using the law to improve access to treatments.
    Elliott R; Parmar S; Divan V; Berger J
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):88-94. PubMed ID: 14743817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy.
    Elliott R; Csete J; Wood E; Kerr T
    Health Hum Rights; 2005; 8(2):104-38. PubMed ID: 17136905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International law, human rights and HIV/AIDS.
    Patterson D; London L
    Bull World Health Organ; 2002; 80(12):964-9. PubMed ID: 12571725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patents or patients? Global access to pharmaceuticals and social justice.
    de Wildt G; Khoon CC
    Med Confl Surviv; 2008; 24 Suppl 1():S52-61. PubMed ID: 18771195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On a never-ending waiting list: toward equitable access to anti-retroviral treatment? Experiences from Zambia.
    Jones PS
    Health Hum Rights; 2005; 8(2):76-102. PubMed ID: 17136904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving Human Rights and the Science of Antiretroviral Medicine.
    Kavanagh M; Cohn J; Mabote L; Meier BM; Williams B; Russell A; Sikwese K; Baker B
    Health Hum Rights; 2015 Jun; 17(1):E76-90. PubMed ID: 26204587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taking the fight to their realm: the role of patent oppositions in the struggle for access to medicines.
    Park C
    HIV AIDS Policy Law Rev; 2006 Dec; 11(2-3):84-5. PubMed ID: 17375435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UNGASS Declaration of Commitment on HIV/AIDS: one year later.
    Roseman MJ; Gruskin S
    Can HIV AIDS Policy Law Rev; 2003 Apr; 8(1):1, 7-14. PubMed ID: 12924286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Employing human rights frameworks to realize access to an HIV cure.
    Meier BM; Gelpi A; Kavanagh MM; Forman L; Amon JJ
    J Int AIDS Soc; 2015; 18(1):20305. PubMed ID: 26568056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.